SB-408124 |
N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N’-[4-(dimethylamino)phenyl]urea |
(CAS 288150-92-5) |
 |
Description: |
SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively; exhibits 50-fold selectivity over OX2 receptor.
IC50 Value: 57 nM(Ki)
Target: OX1 Receptor
in vitro: SB-408124 binds hypocretin type 1 receptor (HcrtR1) with pKi values of 7.57. Calcium mobilization studies shows that SB-408124 is a functional antagonist of the OX1 receptor with a affinity of approximately 50-fold selectivity over the OX2 receptor. A recent study indicates that pretreatment of primary cultures of rat astrocytes with SB-401824 before Orexin A administration significantly reduced the stimulatory action of Orexin A on both basal and forskolin-acivated cAMP production.
in vivo: SB-408124 (30 μg/10 μL, administered intracerebroventricularly) decreases Orexin-A induced water intake in Wistar rats. Intracerebroventricularly administered Orexin-A (30 μg/10 μL) blocks the vasopressin (VP) level increase induced by either histamine or 2.5% NaCl administration, and this blocking effect is moderated by pretreatment with SB-408124. Intracerebroventricular pretreatment with SB-408124 (50 mM, 5 μL/h) prevents Bicuculline (BIC)-induced increases in endogenous glucose production (EGP).
|
Product No. |
KT20318 |
Product Name |
SB-408124 |
Synonyms |
SB 408124; SB408124 |
Formal Name |
N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N’-[4-(dimethylamino)phenyl]urea |
CAS Number |
288150-92-5 |
Molecular Formula |
C19H18F2N4O |
Formula Weight |
356.37 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Orexin Receptor
Almorexant
MK-3697
SB-334867
SB-408124
SB-674042
Suvorexant
TCS 1102
|
|